ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$17.66 USD
+0.46 (2.67%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $17.67 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (77 out of 250)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.86 | 1.38 | 9.99 |
Current Quarter Estimate | 0.06 | -2.62 | 63.00 |
Year Ago Quarter Estimate | 0.28 | -4.94 | 52.25 |
Next Quarter Estimate | 0.16 | 2.79 | 66.00 |
Next Year Estimate | 0.82 | 21.45 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 237.84 | 16.80 | 15.67 |
Next Year | 60.78 | 9.80 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 22.64 | -8.36 |
Price/Book (MRQ) | 5.09 | 2.07 |
Price/Cash Flow (MRFY) | NA | 15.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 13.83% | -15.58% |
Return on Equity (TTM) | 25.83% | -14.63% |
Debt to Equity (MRQ) | 0.00 | 4.66 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.